About
Junaid Tantray is an accomplished pharmacologist and Assistant Professor at NIMS Institute of Pharmacy, NIMS University, Jaipur. He holds a B. Pharm and M. Pharm in Pharmacology from Uttarakhand Technical University and is pursuing his PhD at NIMS University. With expertise in drug safety, pharmacovigilance, nanotechnology-based drug delivery, and AI in drug discovery, he has published widely, co-authored a various research and review articles in MDPI, Bentham Sciences, Springer, Elsevier and authored several books and chapters. Junaid serves as editor for upcoming books with International Publishers. He has organized over 30 academic events and webinars. Currently serving as Vice President of APTI J&K Branch and an active member of PharmaLok and SPSR, he promotes academic excellence and industry collaboration.
Employment
-
NIMS University Assistant Professor2022 - Present
-
NIMS University Ass. Professor2022 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (27)
- iNOS-Dependent Cardioprotection by Cilostazol in Ischemia-Reperfusion Injury: Evidence from Isolated Rat Heart Model Save
- Cardioprotective effects of the ranolazine in myocardial infarction mediated by stimulation of the endogenous mediators involved in ischemic preconditioning Save
- Living with myasthenia gravis and future perspective Save
- Polymeric nanoparticles in the treatment of dermatological disorders Save
- Regulatory frameworks for artificial intelligence in patient counseling: Navigating compliance and ethical concerns Save
- Understanding machine learning for patient education Save
- Advances in nose to brain targeted nano drug delivery system for Alzheimer’s disease: Emphasis on preparative techniques, preclinical, clinical, and toxicity assessment Save
- Decoding Brugada syndrome: A comprehensive analysis of pathophysiology, genetic foundations and advanced clinical management Save
- Ivabradine Enhances its Positive Impact on the Heart Muscle/ (Myocardial Infarction) by Modulating Myocardial Nitric Oxide and ATP-dependent K+ Channels but not by Adenosine and Bradykinin Levels Save
- Pharma Products Transformation Through Computer Vision (CV) and Internet of Everything (IoE) Save